Flinders University researchers have discovered a new anti-inflammatory role for well-known blood clot protein fibrinogen, which could support targeted new treatments for kidney, heart and other common diseases.
Feb 1, 2021
0
20
Previous exposure to other coronaviruses may enhance a person's immune response to COVID-19 infection, but new research suggests that antibodies triggered by the SARS outbreak of 2003 provide only limited protection against ...
Feb 1, 2021
0
6
Even as the first vaccines for SARS-CoV-2, the virus that causes COVID-19, are being distributed, scientists and clinicians around the world have remained steadfast in their efforts to better understand how the human immune ...
Jan 27, 2021
0
4
Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational ...
Jan 26, 2021
0
13
There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.
Jan 25, 2021
0
39
In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer's disease can detect ...
Jan 13, 2021
0
31
More and more evidence is coming out that people with COVID-19 are suffering from cognitive effects, such as brain fog and fatigue.
Dec 17, 2020
2
1831
A study by University of Tartu researchers indicates that the sensitivity of tests used to detect viral antibodies in a blood sample may differ significantly. The combination of several tests may give the best result.
Dec 3, 2020
0
3
Scientists said Monday they had developed a way of predicting if patients will develop Alzheimer's disease by analysing their blood, in what experts hailed as a potential "gamechanger" in the fight against the debilitating ...
Nov 30, 2020
0
105
The action of metformin, the classic drug used to treat diabetes by stabilizing blood sugar, can be blocked by a molecule from the bacteria in our intestines, a University of Gothenburg study shows.
Nov 11, 2020
0
5
